Knowledge Management System of Institute of Zoology, CAS
Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs | |
Source Publication | CELL PROLIFERATION
![]() |
2020 | |
Volume | 53Issue:12Pages:e12944 |
Wu J(吴骏); Zhou Xing; Tan YQ(谭元卿); Wang L(王柳); Li TD(李天达); Li ZW(李仲文); Gao TT(高婷婷); Fan JQ(范佳琪); Guo BJ(郭保杰); Li W(李伟); Hao J(郝捷); Wang Xianguang; Hu BY(胡宝洋) | |
Document Type | 期刊论文 |
Identifier | http://ir.ioz.ac.cn/handle/000000/14488 |
Collection | 干细胞与生殖生物学国家重点实验室 |
Recommended Citation GB/T 7714 | Wu J,Zhou Xing,Tan YQ,et al. Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs[J]. CELL PROLIFERATION,2020,53(12):e12944. |
APA | 吴骏.,Zhou Xing.,谭元卿.,王柳.,李天达.,...&胡宝洋.(2020).Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.CELL PROLIFERATION,53(12),e12944. |
MLA | 吴骏,et al."Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs".CELL PROLIFERATION 53.12(2020):e12944. |
Files in This Item: | Download All | |||||
File Name/Size | DocType | Version | Access | License | ||
Phase 1 trial for tr(295KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | View Download |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment